Which MRI scan best spots lung cancer spread to the brain?
NCT ID NCT02250755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 30 adults with lung cancer that had spread to the brain. Researchers compared two standard MRI sequences (T1 and T2*) to see which one better detects and tracks brain metastases after chemotherapy or targeted therapy. The goal is to improve diagnosis and monitoring without adding extra scans or contrast.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MRI with gadolinium contrast
What this could lead to
If successful, this could help doctors choose the best MRI sequence for diagnosing and tracking brain metastases from lung cancer, improving accuracy without extra tests.
What could go wrong
This is a small, completed study with only 30 participants, so results may not apply to all patients. It compares existing techniques, not a new treatment, so impact is limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA METASTATIC TO THE BRAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Salengro CHRU de Lille
Lille, 59037, France